Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huichun Liang

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Oncogene|January 26, 2018
Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesisHuichun Liang, Ji Xiao, Zhongmei Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2024
CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancerWenmin Chen, Yue Wu, Chuanyu Yang, et al.
Cancer Letters|July 10, 2024
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancerHongyan Zhang, Longlong Zhang, Yuna He, et al.
The Journal of Clinical Investigation|June 20, 2018
HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infectionFubing Li, Yang Li, Huichun Liang, et al.
Signal Transduction and Targeted Therapy|July 8, 2025
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growthHuichun Liang, Fubing Li, Huan Fang, et al.
International Journal of Biological Sciences|March 28, 2022
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast CancerYanjie Kong, Wenlong Ren, Huan Fang, et al.
Signal Transduction and Targeted Therapy|August 2, 2022
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasisFubing Li, Huichun Liang, Hua You, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncogene|January 26, 2018
Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesisHuichun Liang, Ji Xiao, Zhongmei Zhou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2024
CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancerWenmin Chen, Yue Wu, Chuanyu Yang, et al.
Cancer Letters|July 10, 2024
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancerHongyan Zhang, Longlong Zhang, Yuna He, et al.
The Journal of Clinical Investigation|June 20, 2018
HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infectionFubing Li, Yang Li, Huichun Liang, et al.
Signal Transduction and Targeted Therapy|July 8, 2025
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growthHuichun Liang, Fubing Li, Huan Fang, et al.
International Journal of Biological Sciences|March 28, 2022
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast CancerYanjie Kong, Wenlong Ren, Huan Fang, et al.
Signal Transduction and Targeted Therapy|August 2, 2022
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasisFubing Li, Huichun Liang, Hua You, et al.
Pageof 2